Drug application
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM, NAPROXEN)
Drugs@FDA ANDA 204470 · ACTAVIS LABS FL INC
Key facts
| Drug name | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
|---|---|
| Active ingredients | ESOMEPRAZOLE MAGNESIUM, NAPROXEN |
| Application type | ANDA |
| Application number | 204470 |
| Company | ACTAVIS LABS FL INC |
| Dosage forms | TABLET, DELAYED RELEASE, ORAL |
| Strength | EQ 20MG BASE;375MG |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Aug 24, 2022 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.